2019 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2021 | 0 | 8.413.640 | 209.063 | 2 | ||
2019 | 0 | 63.273.831 | 311.900 | 2 |
Total number of partners: 157
Partner loyalty:
Frequent Partner: (> 2 projects): 15
Rare Partner: 142
Frequent / Rare Partner Ratio: 0.11
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2021-05-01 | PERSONALISATION OF IMMUNOSUPPRESSION BY MONITORING VIRAL LOAD POST KIDNEY TRANSPLANTATION - A RANDOMISED CONTROLLED PHASE II TRIAL | TTV GUIDE TX | participant | 6.099.831 | 21 |
2021-03-01 | European Rare dIsease research Coordination and support Action | ERICA | participant | 2.313.809 | 27 |
2019-01-01 | NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients | NECESSITY | participant | 8.200.000 | 25 |
2019-01-01 | European Joint Programme on Rare Diseases | EJP RD | participant | 55.073.831 | 88 |